Literature DB >> 3351602

The three-dimensional localization of internal mammary lymph nodes by radionuclide lymphoscintigraphy.

W D Kaplan1, J W Andersen, R L Siddon, B T Connolly, C A McCormick, S M Laffin, E M Rosenbaum, C A Jennings, A Recht, J R Harris.   

Abstract

In breast cancer patients, radiation therapy planning must account for individual anatomy to ensure optimal coverage of tumor and internal mammary nodes. To achieve this, three-dimensional radionuclide lymphoscintigraphy (RNLS) was performed in 167 patients by obtaining two images of the nodes using a 30-degree slant hole collimator rotated 180 degrees between images. Analysis of 768 nodes (mean 4.6/patient) visualized from the level of rib 1 through interspace 5 was performed. The number of nodes seen was not a function of patient age. Cross-communication to the contralateral node chain occurred in 13.8% of cases. Eighty-two percent of nodes were located near the first three ribs and interspaces; 23% were located beyond 3.0 cm from the mid-sternal line. At the level of the radiation beam match line (second rib or interspace), 4.5% of nodes were deeper than 3.0 cm. From rib 3 through interspace 5, 3.9% were deeper than 3.0 cm. Using an idealized tangential field, at least one node would have been missed in 16.2% of patients. Three-dimensional RNLS allows definition and localization of normal sized nodes and ensures that radiation therapy portals can be tailored for each individual under treatment.

Entities:  

Mesh:

Year:  1988        PMID: 3351602

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  1 in total

1.  Development and characterization of an all-in-one gamma probe with auto-peak detection for sentinel lymph node biopsy based on NEMA NU3-2004 standard.

Authors:  Aram Radnia; Hamed Abdollahzadeh; Behnoosh Teimourian; Mohammad Hossein Farahani; Mohammad Esmaeil Akbari; Habib Zaidi; Mohammad Reza Ay
Journal:  Ann Nucl Med       Date:  2021-01-19       Impact factor: 2.668

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.